Article
GluK2 Is a Target for Gene Therapy in Drug‐Resistant Temporal Lobe Epilepsy
21 Jun 2023
Abstract excerpt
OBJECTIVE: Temporal lobe epilepsy (TLE) is characterized by recurrent seizures generated in the limbic system, particularly in the hippocampus. In TLE, recurrent mossy fiber sprouting from dentate gyrus granule cells (DGCs) crea an aberrant epileptogenic network between DGCs which operates via ectopically expressed GluK2/GluK5-containing kainate receptors (KARs). TLE patients are often resistant to anti-seizure...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
